PUMA BIOTECHNOLOGY INC (PBYI)

US74587V1070 - Common Stock

2.95  -0.17 (-5.45%)

After market: 3.056 +0.11 (+3.59%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
243.57M235.64M228.00M253.20M225.10M
Cost Of Goods
74.81M62.68M55.10M63.70M39.40M
Gross Profit
168.76M172.96M172.90M189.50M185.70M
Operating Expenses
136.36M139.69M149.20M188.20M216.10M
Research and Development
52.64M50.38M59.20M71.90M97.70M
Selling, General, and Administrative Expenses
83.72M89.31M90.00M116.30M118.50M
Operating Income
32.40M33.27M23.80M1.30M-30.40M
Interest Income/Expense
-8.97M-10.72M-10.80M-12.60M-13.60M
Other Income/Expense
1.24M759.00K0.00300.00K400.00K
Non Recurring Items
N/A-625.00K-12.50M-17.70M-16.20M
Income Before Taxes
24.67M22.67M500.00K-28.80M-59.80M
Income Tax
1.43M1.08M500.00K300.00K200.00K
Net Income
23.24M21.59M0.00-29.10M-60.00M
EBITDA
43.97M44.78M32.72M11.90M-20.37M
 
Per Share Data
EPS Diluted Total Ops
0.470.450.00-0.72-1.52
Non GAAP EPS
0.480.46-0.00-0.53-1.52
 
Statistics
Gross Profit Margin
69.29%73.40%75.83%74.84%82.50%
Profit Margin
9.54%9.16%N/A-11.49%-26.65%
Operating Profit Margin
13.30%14.12%10.44%0.51%-13.51%

All data in USD

Charts